EBVdb: a data mining system for knowledge discovery in Epstein-Barr virus with applications in T cell immunology and vaccinology
暂无分享,去创建一个
[1] V. Brusic,et al. FluKB: A Knowledge-Based System for Influenza Vaccine Target Discovery and Analysis of the Immunological Properties of Influenza Viruses , 2015, Journal of immunology research.
[2] J. Cohen. Epstein–barr virus vaccines , 2015, Clinical & translational immunology.
[3] Deborah Hix,et al. The immune epitope database (IEDB) 3.0 , 2014, Nucleic Acids Res..
[4] Vladimir Brusic,et al. Big Data Analytics in Immunology: A Knowledge-Based Approach , 2014, BioMed research international.
[5] M. Rowe,et al. Epstein Barr virus entry; kissing and conjugation. , 2014, Current opinion in virology.
[6] Vladimir Brusic,et al. HPVdb: a data mining system for knowledge discovery in human papillomavirus with applications in T cell immunology and vaccinology , 2013, BCB.
[7] P. Farrell,et al. Epstein-Barr Virus Sequence Variation—Biology and Disease , 2012, Pathogens.
[8] Anthony Epstein. Burkitt lymphoma and the discovery of Epstein–Barr virus , 2012, British journal of haematology.
[9] V. Brusic,et al. FLAVIdB: A data mining system for knowledge discovery in flaviviruses with direct applications in immunology and vaccinology , 2013, Immunome research.
[10] W. Wilson,et al. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. , 2011, Blood.
[11] O. Lund,et al. NetMHCIIpan-2.0 - Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure , 2010, Immunome research.
[12] G. Klein,et al. Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes. , 2010, Biochemical and biophysical research communications.
[13] Hao Liu,et al. Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. , 2010, Blood.
[14] Baris E. Suzek,et al. The Universal Protein Resource (UniProt) in 2010 , 2009, Nucleic Acids Res..
[15] María Martín,et al. The Universal Protein Resource (UniProt) in 2010 , 2010 .
[16] E. Robertson. Epstein-barr virus : latency and transformation , 2010 .
[17] H. Heslop,et al. Immunotherapy for Epstein-Barr Virus-Related Lymphomas , 2009, Mediterranean journal of hematology and infectious diseases.
[18] Vladimir Brusic,et al. Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research , 2008, BMC Bioinformatics.
[19] O. Lund,et al. NetMHCpan, a method for MHC class I binding prediction beyond humans , 2008, Immunogenetics.
[20] V. Brusic,et al. Evaluation of MHC class I peptide binding prediction servers: Applications for vaccine research , 2008, BMC Immunology.
[21] G. Klein,et al. Epstein–Barr virus infection in humans: from harmless to life endangering virus–lymphocyte interactions , 2007, Oncogene.
[22] Chung-Che Chang,et al. Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals , 2006, Nature Medicine.
[23] Gregory D. Schuler,et al. Database resources of the National Center for Biotechnology Information: update , 2004, Nucleic acids research.
[24] K. Katoh,et al. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. , 2002, Nucleic acids research.
[25] D. Srivastava,et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. , 1998, Blood.
[26] R. Krance,et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation , 1995, The Lancet.
[27] E. Myers,et al. Basic local alignment search tool. , 1990, Journal of molecular biology.
[28] E. Kieff,et al. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes , 1990, Journal of virology.
[29] P. L. Deininger,et al. DNA sequence and expression of the B95-8 Epstein—Barr virus genome , 1984, Nature.